Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

A Randomized, Double-Blind, Placebo-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.

Inclusion Criteria:

• Male and female subjects aged above 20
• Patient with overactive bladder symptoms lasting at least 6 months

Exclusion Criteria:

• Patient with a history of surgery or a disease that may affect bladder function.